Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Respiratory Medicine
|
May 1, 2014
Quantifying preferences for asthma control in parents and adolescents using best-worst scaling
Wendy J Ungar, Anahita Hadioonzadeh, Mehdi Najafzadeh, et al.
Clinical Pharmacology and Therapeutics
|
August 15, 2018
Using Real-World Data to Extrapolate Evidence From Randomized Controlled Trials
Shirley V Wang, Sebastian Schneeweiss, Joshua J Gagne, et al.
The American Journal of Managed Care
|
May 31, 2017
Economic value of pharmacist-led medication reconciliation for reducing medication errors after hospital discharge
Mehdi Najafzadeh, Jeffrey L Schnipper, William H Shrank, et al.
Clinical Pharmacology and Therapeutics
|
October 19, 2023
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiopulmonary Hospitalization or Mortality: Emulating the INVESTED Trial Using Insurance Claims Data
Mehdi NajafZadeh, HoJin Shin, Sebastian Schneeweiss, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 22, 2010
Cost-effectiveness of the addition of rituximab to CHOP chemotherapy in first-line treatment for diffuse large B-cell lymphoma in a population-based observational cohort in British Columbia, Canada
Karissa M Johnston, Carlo A Marra, Joseph M Connors, et al.
Circulation. Cardiovascular Quality and Outcomes
|
November 13, 2014
Patients' preferences in anticoagulant therapy: discrete choice experiment
Mehdi Najafzadeh, Joshua J Gagne, Niteesh K Choudhry, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
January 14, 2012
Barriers to integrating personalized medicine into clinical practice: a best-worst scaling choice experiment
Mehdi Najafzadeh, Larry D Lynd, Jennifer C Davis, et al.
Plos One
|
October 17, 2012
Future impact of various interventions on the burden of COPD in Canada: a dynamic population model
Mehdi Najafzadeh, Carlo A Marra, Larry D Lynd, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 17, 2015
A unified framework for classification of methods for benefit-risk assessment
Mehdi Najafzadeh, Sebastian Schneeweiss, Niteesh Choudhry, et al.
Clinical Pharmacology and Therapeutics
|
June 27, 2023
Predicting Treatment Effects of a New-to-Market Drug in Clinical Practice Based on Phase III Randomized Trial Results
HoJin Shin, Shirley V Wang, Dae Hyun Kim, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Respiratory Medicine
|
May 1, 2014
Quantifying preferences for asthma control in parents and adolescents using best-worst scaling
Wendy J Ungar, Anahita Hadioonzadeh, Mehdi Najafzadeh, et al.
Clinical Pharmacology and Therapeutics
|
August 15, 2018
Using Real-World Data to Extrapolate Evidence From Randomized Controlled Trials
Shirley V Wang, Sebastian Schneeweiss, Joshua J Gagne, et al.
The American Journal of Managed Care
|
May 31, 2017
Economic value of pharmacist-led medication reconciliation for reducing medication errors after hospital discharge
Mehdi Najafzadeh, Jeffrey L Schnipper, William H Shrank, et al.
Clinical Pharmacology and Therapeutics
|
October 19, 2023
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiopulmonary Hospitalization or Mortality: Emulating the INVESTED Trial Using Insurance Claims Data
Mehdi NajafZadeh, HoJin Shin, Sebastian Schneeweiss, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 22, 2010
Cost-effectiveness of the addition of rituximab to CHOP chemotherapy in first-line treatment for diffuse large B-cell lymphoma in a population-based observational cohort in British Columbia, Canada
Karissa M Johnston, Carlo A Marra, Joseph M Connors, et al.
Circulation. Cardiovascular Quality and Outcomes
|
November 13, 2014
Patients' preferences in anticoagulant therapy: discrete choice experiment
Mehdi Najafzadeh, Joshua J Gagne, Niteesh K Choudhry, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
January 14, 2012
Barriers to integrating personalized medicine into clinical practice: a best-worst scaling choice experiment
Mehdi Najafzadeh, Larry D Lynd, Jennifer C Davis, et al.
Plos One
|
October 17, 2012
Future impact of various interventions on the burden of COPD in Canada: a dynamic population model
Mehdi Najafzadeh, Carlo A Marra, Larry D Lynd, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 17, 2015
A unified framework for classification of methods for benefit-risk assessment
Mehdi Najafzadeh, Sebastian Schneeweiss, Niteesh Choudhry, et al.
Clinical Pharmacology and Therapeutics
|
June 27, 2023
Predicting Treatment Effects of a New-to-Market Drug in Clinical Practice Based on Phase III Randomized Trial Results
HoJin Shin, Shirley V Wang, Dae Hyun Kim, et al.
Page
of 6